GBA's "2021 Stock Phantasma"

Discussion in 'Stocks' started by stonedinvestor, Jan 1, 2021.

  1. It was $16.50 and it jumped. Should have even more vol right?

    Volume 1,231,258 / Avg. Volume 140,142
     
    #6351     Jul 1, 2021
  2. vanzandt

    vanzandt

    Yeah its bouncing. $16.65 now.
    I say buy it but close it before 4PM.
    Just betting on a squeeze really.
    That's what the chart looks like anyway.
    Stop it out at $16.40

    Edit.. and no sooner did I write that....bam.... $16.40
     
    Last edited: Jul 1, 2021
    #6352     Jul 1, 2021
  3. Agrify Corporation (AGFY)- Once I was $8 now I am found!
    NasdaqGS - NasdaqGS Real Time Price. Currency in USD

    $12.93+1.03 (+8.66%)<--------:thumbsup:
     
    #6353     Jul 1, 2021
  4. vanzandt

    vanzandt

    #6354     Jul 1, 2021
  5. JPMorgan starts Nexi with Overweight on 'enhanced growth' 06:02 NEXXY JPMorgan analyst Sandeep Deshpande last night initiated coverage of Nexi with an Overweight rating and EUR 23 price target. Nexi is a European payments market consolidator that benefits from market re-openings, scale through acquisitions, synergies from future deals and "enhanced growth" due to greater than 70% of the combined company's exposure to under-penetrated payment market, Deshpande tells investors in a research note.
     
    #6355     Jul 2, 2021
  6. GrowGeneration
    GrowGeneration may not have yet become a household name, but it is a fast-emerging retail chain that profits from selling equipment and supplies for growing cannabis. It currently operates 55 stores between California and Maine. As legal restrictions on marijuana steadily loosen, GrowGeneration's potential market continues to expand rapidly.

    The company expects to grow to 100 stores by 2023, and it has set a goal of operating in all 50 states. GrowGeneration also continues to expand its portfolio of private label products. These offerings can bring a level of specialization not found with the numerous other competitors in the industry. Additionally, while Home Depot and Lowe's also sell hydroponic products, they likely will lack the shelf space to offer GrowGeneration's level of specialization.

    The company's growth certainly shows this demand. In the first quarter of 2021, record revenue of $90 million represented a 173% increase from the same quarter last year. The company also earned $6.1 million during the quarter compared with a Q1 2020 reported loss of $2.1 million. Limiting operating expense growth to 59% contributed to the positive net income.

    Investors should not assume this was a one-time event. Revenue in 2020 increased 143%, and net income surged 203% from 2019 levels. Also, same-store sales rose 63% for the year, exceeding the 53% increase in Q1 2021. Furthermore, considering the company revenue growth projection of between $450 million and $470 million for 2021, the triple-digit increases should continue for the foreseeable future.

    Admittedly, much of this growth happened due to share dilution as the 58.4 million basic shares outstanding far exceeds the 37.8 million available at the end of Q1 2020. Nonetheless, GrowGeneration invested the proceeds back into the company as the store count has approximately doubled since that time.

    It also did not stop the stock from moving higher, as the share price has surged by just over 480% over the last 12 months. Interestingly, the P/E ratio of 180 has fallen during that period. Moreover, considering the earnings growth, that multiple may not deter investors. As increased cannabis legalization continues to fuel production, GrowGeneration will likely continue to bring growth to its long-term stockholders.

    [​IMG]
     
    #6356     Jul 2, 2021
  7. -
    Village Farms approval increases production capacity by 50%, says Roth Capital 07:32 VFF

    Craig-Hallum says Magnite SpringServe deal more consequential than price implies 07:15 MGNI, GOOGL, GOOG, CMCSA After Magnite (MGNI) announced the acquisition of video ad server SpringServe for $31M, Craig-Hallum analyst Jason Kreyer said he believes the acquisition "could be nearly as consequential for the company as the Telaria and SpotX deals" even though the financial obligation and contribution is "negligible." In an ad server market currently dominated by Google (GOOGL) and Comcast's (CMCSA) Freewheel, his talks with industry experts suggest an alternative ad server, housed in a fully integrated ad stack, from an independent provider, would be "a very welcomed alternative," said Kreyer, who believes the acquisition of SpringServe will allow Magnite to capture incremental wallet share for its publishers. He reiterates a Buy rating and $50 price target on Magnite shares.
     
    #6357     Jul 2, 2021
  8. I just spun around a few bio charts and I really like the looks of Ironwood. We highlighted this stk at $10-$11 I have a long history of following the company. In my view it is under priced by 100%.

    • Ironwood Pharmaceuticals (IRWD) director Alexander Denner purchased 775,000 shares of company stock at $10.01 per share for a total transaction amount of $7,758,758
    Ironwood Pharmaceuticals, Inc. (IRWD)- Van we should of bought this initially!


    $12.93+0.06 (+0.47%)
     
    #6358     Jul 2, 2021
    vanzandt likes this.
  9. June 11->

    Magnite partnerships can help accelerate shift in spend to CTV, says Stephens 06/11 MGNI, TTD Stephens analyst Nicholas Zangler said he like Magnite's (MGNI) recently announced IRIS.TV and tvScientific partnerships, which he thinks can help accelerate the "inevitable shift in ad spend" from linear TV and search/social into the Connected TV segment. The analyst, who believes that over time "virtually all linear TV advertising will be converted to CTV," keeps a Buy rating and $48 price target on Magnite shares, but argues the stock "would be trading at $60" if it was awarded the multiple granted to Trade Desk (TTD).
     
    #6359     Jul 2, 2021
  10. 1- MGNI

    2- IRWD

    3- SPRO
     
    #6360     Jul 2, 2021